Number of the records: 1  

Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure

  1. 1.
    SYSNO ASEP0509188
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAltered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure
    Author(s) Vacková, Š. (CZ)
    Kikerlová, S. (CZ)
    Melenovský, V. (CZ)
    Kolář, František (FGU-C) RID, ORCID, SAI
    Imig, J. D. (US)
    Kompanowska - Jezierska, E. (PL)
    Sadowski, J. (PL)
    Červenka, L. (CZ)
    Source TitleKidney & Blood Pressure Research. - : Karger - ISSN 1420-4096
    Roč. 44, č. 4 (2019), s. 792-809
    Number of pages18 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordscongestive heart failure ; hypertension ; aorto-caval fistula ; renal blood flow ; renal dysfunction ; renal vascular reactivity ; angiotensin II ; epoxyeicosatrienoic acid
    Subject RIVFA - Cardiovascular Diseases incl. Cardiotharic Surgery
    OECD categoryCardiac and Cardiovascular systems
    R&D ProjectsNV18-02-00053 GA MZd - Ministry of Health (MZ)
    Method of publishingOpen access
    Institutional supportFGU-C - RVO:67985823
    UT WOS000483857700028
    EID SCOPUS85071709898
    DOI10.1159/000501688
    AnnotationObjective: We evaluated the hypothesis that the development of renal dysfunction and congestive heart failure (CHF) caused by volume overload in rats with angiotensin II (ANG II)-dependent hypertension is associated with altered renal vascular responsiveness to ANG II and to epoxyeicosatrienoic acids (EETs). Methods: Ren-2 transgenic rats (TGRs) were used as a model of ANG II-dependent hypertension. CHF was induced by volume overload achieved by the creation of the aorto-caval fistula (ACF). Renal blood flow (RBF) responses were determined to renal arterial administration of ANG II, native 11,12-EET, an analog of 14,15-EETs (EET-A), norepinephrine (NE), acetylcholine (Ach) and bradykinin (Bk) in healthy (i.e., sham-operated) TGR and ACF TGR (5 weeks after ACF creation). Results: Selective intrarenal administration of neither vasoactive drug altered mean arterial pressure in any group. Administration of ANG II caused greater decreases in RBF in ACF TGR than in sham-operated TGR, whereas after administration of NE the respective decreases were comparable in the 2 groups. Administration of Ach and Bk elicited significantly higher RBF increases in ACF TGR as compared with sham-operated TGR. In contrast, administration of 11,12-EET and EET-A caused significantly smaller RBF increases in ACF TGR than in sham-operated TGR. Conclusion: The findings show that 5 weeks after creation of ACF, the TGR exhibit exaggerated renal vasoconstrictor responses to ANG II and reduced renal vasodilatory responses to EETs, suggesting that both these alterations might play an important role in the development of renal dysfunction in this model of CHF.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2020
    Electronic addresshttps://doi.org/10.1159/000501688
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.